25 XP   0   0   10

Aura Biosciences Inc
Buy, Hold or Sell?

Let's analyse Aura Biosciences Inc together

PenkeI guess you are interested in Aura Biosciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Aura Biosciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Aura Biosciences Inc

I send you an email if I find something interesting about Aura Biosciences Inc.

Quick analysis of Aura Biosciences Inc (30 sec.)










What can you expect buying and holding a share of Aura Biosciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$4.58
Expected worth in 1 year
$5.19
How sure are you?
30.8%

+ What do you gain per year?

Total Gains per Share
$0.61
Return On Investment
8.5%

For what price can you sell your share?

Current Price per Share
$7.19
Expected price per share
$5.99 - $8.5
How sure are you?
50%

1. Valuation of Aura Biosciences Inc (5 min.)




Live pricePrice per Share (EOD)

$7.19

Intrinsic Value Per Share

$-20.90 - $-24.73

Total Value Per Share

$-16.33 - $-20.15

2. Growth of Aura Biosciences Inc (5 min.)




Is Aura Biosciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$225.8m$145.2m$35.8m19.8%

How much money is Aura Biosciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$18.5m-$20.8m$2.3m12.7%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Aura Biosciences Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#229 / 1016

Most Revenue
#872 / 1016

Most Profit
#682 / 1016

Most Efficient
#315 / 1016

What can you expect buying and holding a share of Aura Biosciences Inc? (5 min.)

Welcome investor! Aura Biosciences Inc's management wants to use your money to grow the business. In return you get a share of Aura Biosciences Inc.

What can you expect buying and holding a share of Aura Biosciences Inc?

First you should know what it really means to hold a share of Aura Biosciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Aura Biosciences Inc is $7.19. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Aura Biosciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Aura Biosciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $4.58. Based on the TTM, the Book Value Change Per Share is $0.15 per quarter. Based on the YOY, the Book Value Change Per Share is $0.22 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Aura Biosciences Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.45-6.2%-0.39-5.4%-0.30-4.1%-0.29-4.1%-0.29-4.1%
Usd Book Value Change Per Share1.5020.9%0.152.1%0.223.0%0.354.9%0.354.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share1.5020.9%0.152.1%0.223.0%0.354.9%0.354.9%
Usd Price Per Share8.86-9.87-16.20-9.33-9.33-
Price to Earnings Ratio-4.94--6.45--14.00--7.54--7.54-
Price-to-Total Gains Ratio5.90--24.54--53.06--33.39--33.39-
Price to Book Ratio1.94-2.76-5.88-3.08-3.08-
Price-to-Total Gains Ratio5.90--24.54--53.06--33.39--33.39-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share7.19
Number of shares139
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.150.35
Usd Total Gains Per Share0.150.35
Gains per Quarter (139 shares)21.3148.93
Gains per Year (139 shares)85.24195.73
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1085750196186
201701600391382
302562450587578
403413300783774
504264150979970
60511500011741166
70597585013701362
80682670015661558
90767755017621754
100852840019571950

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.013.00.00.0%0.013.00.00.0%0.013.00.00.0%
Book Value Change Per Share1.03.00.025.0%4.07.01.033.3%4.08.01.030.8%4.08.01.030.8%4.08.01.030.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.013.00.0%0.00.013.00.0%0.00.013.00.0%
Total Gains per Share1.03.00.025.0%4.07.01.033.3%4.08.01.030.8%4.08.01.030.8%4.08.01.030.8%

Fundamentals of Aura Biosciences Inc

About Aura Biosciences Inc

Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. The company also focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer as an alternative to bacillus calmette"guérin therapy. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.

Fundamental data was last updated by Penke on 2024-03-31 10:12:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Aura Biosciences Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Aura Biosciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Aura Biosciences Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Aura Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--199.6%+199.6%
TTM--213.0%+213.0%
YOY--279.3%+279.3%
5Y--438.4%+438.4%
10Y--605.5%+605.5%
1.1.2. Return on Assets

Shows how efficient Aura Biosciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Aura Biosciences Inc to the Biotechnology industry mean.
  • -8.7% Return on Assets means that Aura Biosciences Inc generated $-0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Aura Biosciences Inc:

  • The MRQ is -8.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -9.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.7%TTM-9.0%+0.3%
TTM-9.0%YOY-12.0%+3.1%
TTM-9.0%5Y-12.2%+3.3%
5Y-12.2%10Y-12.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.7%-13.5%+4.8%
TTM-9.0%-12.9%+3.9%
YOY-12.0%-11.8%-0.2%
5Y-12.2%-14.1%+1.9%
10Y-12.2%-16.0%+3.8%
1.1.3. Return on Equity

Shows how efficient Aura Biosciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Aura Biosciences Inc to the Biotechnology industry mean.
  • -9.8% Return on Equity means Aura Biosciences Inc generated $-0.10 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Aura Biosciences Inc:

  • The MRQ is -9.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -10.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.8%TTM-10.4%+0.6%
TTM-10.4%YOY-13.6%+3.2%
TTM-10.4%5Y-9.0%-1.4%
5Y-9.0%10Y-9.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.8%-16.9%+7.1%
TTM-10.4%-16.1%+5.7%
YOY-13.6%-15.1%+1.5%
5Y-9.0%-19.9%+10.9%
10Y-9.0%-20.9%+11.9%

1.2. Operating Efficiency of Aura Biosciences Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Aura Biosciences Inc is operating .

  • Measures how much profit Aura Biosciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Aura Biosciences Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Aura Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--295.1%+295.1%
TTM--225.8%+225.8%
YOY--288.4%+288.4%
5Y--477.4%+477.4%
10Y--625.6%+625.6%
1.2.2. Operating Ratio

Measures how efficient Aura Biosciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Aura Biosciences Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.090-3.090
TTM-3.264-3.264
YOY-3.783-3.783
5Y-5.679-5.679
10Y-7.894-7.894

1.3. Liquidity of Aura Biosciences Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Aura Biosciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 18.76 means the company has $18.76 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Aura Biosciences Inc:

  • The MRQ is 18.758. The company is very able to pay all its short-term debts. +2
  • The TTM is 18.416. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ18.758TTM18.416+0.342
TTM18.416YOY20.077-1.661
TTM18.4165Y18.713-0.297
5Y18.71310Y18.7130.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ18.7583.914+14.844
TTM18.4164.220+14.196
YOY20.0775.388+14.689
5Y18.7136.045+12.668
10Y18.7136.406+12.307
1.3.2. Quick Ratio

Measures if Aura Biosciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Aura Biosciences Inc to the Biotechnology industry mean.
  • A Quick Ratio of 33.28 means the company can pay off $33.28 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Aura Biosciences Inc:

  • The MRQ is 33.281. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 31.166. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ33.281TTM31.166+2.115
TTM31.166YOY26.279+4.888
TTM31.1665Y22.169+8.998
5Y22.16910Y22.1690.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ33.2813.572+29.709
TTM31.1663.998+27.168
YOY26.2795.390+20.889
5Y22.1695.969+16.200
10Y22.1696.287+15.882

1.4. Solvency of Aura Biosciences Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Aura Biosciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Aura Biosciences Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.11 means that Aura Biosciences Inc assets are financed with 11.5% credit (debt) and the remaining percentage (100% - 11.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Aura Biosciences Inc:

  • The MRQ is 0.115. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.133. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.115TTM0.133-0.018
TTM0.133YOY0.101+0.032
TTM0.1335Y1.178-1.045
5Y1.17810Y1.1780.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1150.336-0.221
TTM0.1330.334-0.201
YOY0.1010.269-0.168
5Y1.1780.366+0.812
10Y1.1780.390+0.788
1.4.2. Debt to Equity Ratio

Measures if Aura Biosciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Aura Biosciences Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 12.9% means that company has $0.13 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Aura Biosciences Inc:

  • The MRQ is 0.129. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.154. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.129TTM0.154-0.024
TTM0.154YOY0.118+0.036
TTM0.1545Y0.114+0.040
5Y0.11410Y0.1140.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1290.382-0.253
TTM0.1540.396-0.242
YOY0.1180.335-0.217
5Y0.1140.434-0.320
10Y0.1140.465-0.351

2. Market Valuation of Aura Biosciences Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Aura Biosciences Inc generates.

  • Above 15 is considered overpriced but always compare Aura Biosciences Inc to the Biotechnology industry mean.
  • A PE ratio of -4.94 means the investor is paying $-4.94 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Aura Biosciences Inc:

  • The EOD is -4.008. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.939. Based on the earnings, the company is expensive. -2
  • The TTM is -6.450. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.008MRQ-4.939+0.931
MRQ-4.939TTM-6.450+1.511
TTM-6.450YOY-14.003+7.553
TTM-6.4505Y-7.538+1.088
5Y-7.53810Y-7.5380.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.008-2.259-1.749
MRQ-4.939-2.569-2.370
TTM-6.450-2.664-3.786
YOY-14.003-4.120-9.883
5Y-7.538-6.258-1.280
10Y-7.538-6.171-1.367
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Aura Biosciences Inc:

  • The EOD is -5.011. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -6.174. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -7.629. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.011MRQ-6.174+1.164
MRQ-6.174TTM-7.629+1.455
TTM-7.629YOY-15.306+7.677
TTM-7.6295Y-8.306+0.676
5Y-8.30610Y-8.3060.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.011-2.924-2.087
MRQ-6.174-3.246-2.928
TTM-7.629-3.488-4.141
YOY-15.306-5.620-9.686
5Y-8.306-8.315+0.009
10Y-8.306-8.826+0.520
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Aura Biosciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.94 means the investor is paying $1.94 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Aura Biosciences Inc:

  • The EOD is 1.571. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.936. Based on the equity, the company is underpriced. +1
  • The TTM is 2.764. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.571MRQ1.936-0.365
MRQ1.936TTM2.764-0.828
TTM2.764YOY5.884-3.119
TTM2.7645Y3.084-0.320
5Y3.08410Y3.0840.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.5711.851-0.280
MRQ1.9362.090-0.154
TTM2.7642.095+0.669
YOY5.8842.844+3.040
5Y3.0843.466-0.382
10Y3.0843.815-0.731
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Aura Biosciences Inc.

3.1. Institutions holding Aura Biosciences Inc

Institutions are holding 83.798% of the shares of Aura Biosciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Matrix Capital Management Company, LLC14.05380.63136922870156000029.0889
2023-12-31Eventide Asset Management, LLC11.77970.83925802682277777791.8302
2023-12-31Adage Capital Partners Gp LLC8.5770.07754225000135000046.9565
2023-12-31Medicxi Ventures Management (Jersey) Ltd6.17119.0921303989200
2023-12-31Nantahala Capital Management, LLC5.36690.700626437201899828255.3903
2023-09-30Citadel Advisors Llc5.04280.00482484067234860.9545
2023-12-31BlackRock Inc4.26060.0005209874523471912.592
2023-12-31Goldman Sachs Group Inc4.21150.001720745981081396108.8798
2023-12-31Vanguard Group Inc3.51290.0003173043169933767.8248
2023-12-31Regency Capital Management Inc.\DE1.43114.199170497417799633.7767
2023-12-31Geode Capital Management, LLC1.37260.000667612814969028.4345
2023-12-31T. Rowe Price Associates, Inc.1.33920.000865969226630.4053
2023-12-31Franklin Resources Inc1.21830.00256001186001180
2023-12-31Decheng Capital LLC1.04661.27625155555155550
2023-12-31State Street Corporation1.02770.00025062624890210.6922
2023-12-31Ensign Peak Advisors Inc0.72520.00633572223572220
2023-12-31FMR Inc0.72480.0002357035-1526-0.4256
2023-12-31Long Focus Capital Management, LLC0.69110.100334042214524774.4189
2023-12-31Northern Trust Corp0.50430.00042484312684212.1134
2023-12-31Monashee Investment Management LLC0.40280.31031984151984150
Total 73.4617.244936186259+11847667+32.7%

3.2. Funds holding Aura Biosciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Eventide Healthcare & Life Sciences I11.77973.08445802682277777791.8302
2024-02-29Vanguard Total Stock Mkt Idx Inv1.72090.0005847693-76600-8.2874
2024-02-29Franklin Biotechnology Discv A(acc)USD1.63290.395380435119205131.3655
2024-02-29iShares Russell 2000 ETF1.31770.0094649104-106-0.0163
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.21630.0053599167-1932-0.3214
2023-12-31T. Rowe Price Health Sciences0.96310.02864744194744190
2024-02-29Franklin Biotechnology Discovery A0.82010.38140396512166543.0978
2024-01-31Fidelity Select Biotechnology0.59740.0491294292-62200-17.4478
2023-12-31Fidelity Small Cap Index0.55790.009627480941871.5472
2024-02-01iShares Russell 2000 Value ETF0.52790.01712600193280.1263
2024-01-31Fidelity Extended Market Index0.41140.004420265720681.031
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.33190.003616351300
2024-02-29Vanguard Russell 2000 ETF0.20390.009610042878328.4582
2024-02-29State St Russell Sm Cap® Indx SL Cl I0.20280.00969989700
2023-12-31BlackRock Extended Equity Market K0.16780.0053826553565575.8617
2023-12-31NT R2000 Value Index Fund - NL0.15510.017976383-2884-3.6383
2023-12-31NT R2000 Index Fund - NL0.1540.009375842-2760-3.5114
2024-01-31DFA US Micro Cap I0.13080.00736440900
2024-02-29Schwab Small Cap Index0.12770.009762886-3200-4.8422
2024-02-29iShares Micro-Cap ETF0.12610.06186213500
Total 23.14544.118811401306+3466300+30.4%

3.3. Insider Transactions

Insiders are holding 7.295% of the shares of Aura Biosciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-01-23Julie B FederSELL66097.64
2024-01-23Los Pinos Elisabet DeSELL158537.64
2023-11-09Matrix Capital Management CompBUY15600009
2023-11-07David Michael JohnsonBUY760007.17
2023-11-06Julie B FederSELL390012.07
2023-11-06Los Pinos Elisabet DeSELL744912.03
2023-10-30Julie B FederSELL33856.82
2023-10-30Los Pinos Elisabet DeSELL95866.83
2023-10-03David Michael JohnsonBUY135008.27

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Aura Biosciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.5020.153+880%0.219+585%0.352+327%0.352+327%
Book Value Per Share--4.5763.669+25%2.942+56%1.847+148%1.847+148%
Current Ratio--18.75818.416+2%20.077-7%18.713+0%18.713+0%
Debt To Asset Ratio--0.1150.133-14%0.101+14%1.178-90%1.178-90%
Debt To Equity Ratio--0.1290.154-16%0.118+9%0.114+14%0.114+14%
Dividend Per Share----0%-0%-0%-0%
Eps---0.448-0.387-14%-0.298-34%-0.293-35%-0.293-35%
Free Cash Flow Per Share---0.359-0.327-9%-0.282-21%-0.247-31%-0.247-31%
Free Cash Flow To Equity Per Share--1.5250.166+820%0.202+654%0.321+376%0.321+376%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---24.726--------
Intrinsic Value_10Y_min---20.903--------
Intrinsic Value_1Y_max---1.255--------
Intrinsic Value_1Y_min---1.232--------
Intrinsic Value_3Y_max---4.702--------
Intrinsic Value_3Y_min---4.470--------
Intrinsic Value_5Y_max---9.273--------
Intrinsic Value_5Y_min---8.526--------
Market Cap354832252.000-23%437248088.000486845642.000-10%799359583.000-45%460215191.077-5%460215191.077-5%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio1.571-23%1.9362.764-30%5.884-67%3.084-37%3.084-37%
Pe Ratio-4.008+19%-4.939-6.450+31%-14.003+183%-7.538+53%-7.538+53%
Price Per Share7.190-23%8.8609.865-10%16.198-45%9.325-5%9.325-5%
Price To Free Cash Flow Ratio-5.011+19%-6.174-7.629+24%-15.306+148%-8.306+35%-8.306+35%
Price To Total Gains Ratio4.787-23%5.898-24.540+516%-53.065+1000%-33.390+666%-33.390+666%
Quick Ratio--33.28131.166+7%26.279+27%22.169+50%22.169+50%
Return On Assets---0.087-0.090+3%-0.120+39%-0.122+41%-0.122+41%
Return On Equity---0.098-0.104+6%-0.136+39%-0.090-9%-0.090-9%
Total Gains Per Share--1.5020.153+880%0.219+585%0.352+327%0.352+327%
Usd Book Value--225848000.000181065250.000+25%145203500.000+56%91148000.000+148%91148000.000+148%
Usd Book Value Change Per Share--1.5020.153+880%0.219+585%0.352+327%0.352+327%
Usd Book Value Per Share--4.5763.669+25%2.942+56%1.847+148%1.847+148%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.448-0.387-14%-0.298-34%-0.293-35%-0.293-35%
Usd Free Cash Flow---17704000.000-16139000.000-9%-13923750.000-21%-12205769.231-31%-12205769.231-31%
Usd Free Cash Flow Per Share---0.359-0.327-9%-0.282-21%-0.247-31%-0.247-31%
Usd Free Cash Flow To Equity Per Share--1.5250.166+820%0.202+654%0.321+376%0.321+376%
Usd Market Cap354832252.000-23%437248088.000486845642.000-10%799359583.000-45%460215191.077-5%460215191.077-5%
Usd Price Per Share7.190-23%8.8609.865-10%16.198-45%9.325-5%9.325-5%
Usd Profit---22131000.000-18525500.000-16%-20883500.000-6%-15214923.077-31%-15214923.077-31%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share--1.5020.153+880%0.219+585%0.352+327%0.352+327%
 EOD+2 -6MRQTTM+18 -11YOY+15 -145Y+16 -1310Y+16 -13

4.2. Fundamental Score

Let's check the fundamental score of Aura Biosciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.008
Price to Book Ratio (EOD)Between0-11.571
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than133.281
Current Ratio (MRQ)Greater than118.758
Debt to Asset Ratio (MRQ)Less than10.115
Debt to Equity Ratio (MRQ)Less than10.129
Return on Equity (MRQ)Greater than0.15-0.098
Return on Assets (MRQ)Greater than0.05-0.087
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Aura Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.420
Ma 20Greater thanMa 507.519
Ma 50Greater thanMa 1008.082
Ma 100Greater thanMa 2008.216
OpenGreater thanClose7.030
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Accumulated Other Comprehensive Income  -7227-45-178-22389-134673539



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets255,075
Total Liabilities29,227
Total Stockholder Equity225,848
 As reported
Total Liabilities 29,227
Total Stockholder Equity+ 225,848
Total Assets = 255,075

Assets

Total Assets255,075
Total Current Assets231,794
Long-term Assets23,281
Total Current Assets
Cash And Cash Equivalents 41,082
Short-term Investments 185,087
Other Current Assets 5,625
Total Current Assets  (as reported)231,794
Total Current Assets  (calculated)231,794
+/-0
Long-term Assets
Property Plant Equipment 22,004
Long-term Assets Other 509
Long-term Assets  (as reported)23,281
Long-term Assets  (calculated)22,513
+/- 768

Liabilities & Shareholders' Equity

Total Current Liabilities12,357
Long-term Liabilities16,870
Total Stockholder Equity225,848
Total Current Liabilities
Short-term Debt 2,687
Accounts payable 1,787
Other Current Liabilities 7,883
Total Current Liabilities  (as reported)12,357
Total Current Liabilities  (calculated)12,357
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt16,870
Long-term Liabilities  (as reported)16,870
Long-term Liabilities  (calculated)16,870
+/-0
Total Stockholder Equity
Retained Earnings -287,308
Accumulated Other Comprehensive Income 539
Other Stockholders Equity 512,617
Total Stockholder Equity (as reported)225,848
Total Stockholder Equity (calculated)225,848
+/-0
Other
Cash and Short Term Investments 226,169
Common Stock Shares Outstanding 44,436
Liabilities and Stockholders Equity 255,075
Net Debt -21,525
Net Invested Capital 225,848
Net Working Capital 219,437
Property Plant and Equipment Gross 27,040
Short Long Term Debt Total 19,557



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-30
> Total Assets 
0
22,104
0
98,653
90,704
160,030
146,422
135,021
143,147
223,935
206,019
192,739
179,766
255,075
255,075179,766192,739206,019223,935143,147135,021146,422160,03090,70498,653022,1040
   > Total Current Assets 
18,455
18,455
100,721
92,875
83,458
153,704
139,582
127,669
115,908
196,702
179,121
166,211
153,888
231,794
231,794153,888166,211179,121196,702115,908127,669139,582153,70483,45892,875100,72118,45518,455
       Cash And Cash Equivalents 
0
17,393
0
92,197
81,829
149,063
108,382
53,849
61,110
121,582
38,492
47,732
55,584
41,082
41,08255,58447,73238,492121,58261,11053,849108,382149,06381,82992,197017,3930
       Short-term Investments 
0
0
0
0
0
0
24,899
68,282
50,409
67,229
135,030
114,281
93,472
185,087
185,08793,472114,281135,03067,22950,40968,28224,899000000
       Other Current Assets 
35
16
120
31
55
66
131
261
306
712
5,579
988
566
5,625
5,6255669885,5797123062611316655311201635
   > Long-term Assets 
0
3,649
0
5,778
7,246
6,326
6,840
7,352
27,239
27,233
26,898
26,528
25,878
23,281
23,28125,87826,52826,89827,23327,2397,3526,8406,3267,2465,77803,6490
       Property Plant Equipment 
3,574
3,574
4,306
5,318
5,538
6,201
6,715
6,459
26,471
26,042
25,507
25,060
24,425
22,004
22,00424,42525,06025,50726,04226,4716,4596,7156,2015,5385,3184,3063,5743,574
       Long-term Assets Other 
0
75
0
460
1,708
125
125
893
768
423
623
700
685
509
5096857006234237688931251251,7084600750
       Deferred Long Term Asset Charges 
0
0
0
0
1,583
0
0
0
0
0
0
0
0
0
0000000001,5830000
> Total Liabilities 
0
130,817
0
221,404
22,993
7,715
5,336
5,930
28,093
28,352
25,761
26,302
28,048
29,227
29,22728,04826,30225,76128,35228,0935,9305,3367,71522,993221,4040130,8170
   > Total Current Liabilities 
2,661
2,661
3,421
5,316
5,831
7,272
5,003
5,812
9,964
10,457
8,107
8,895
10,894
12,357
12,35710,8948,8958,10710,4579,9645,8125,0037,2725,8315,3163,4212,6612,661
       Short-term Debt 
0
15
0
601
607
615
624
633
2,942
2,963
2,985
3,008
3,035
2,687
2,6873,0353,0082,9852,9632,9426336246156076010150
       Short Long Term Debt 
0
15
0
0
0
0
0
0
0
0
0
0
0
0
000000000000150
       Accounts payable 
611
611
1,311
2,417
1,736
2,401
1,956
1,198
1,724
2,921
1,055
553
1,490
1,787
1,7871,4905531,0552,9211,7241,1981,9562,4011,7362,4171,311611611
       Other Current Liabilities 
0
262
438
353
735
423
2,423
3,981
5,298
4,573
4,067
766
1,020
7,883
7,8831,0207664,0674,5735,2983,9812,4234237353534382620
   > Long-term Liabilities 
0
128,156
0
216,088
17,162
443
333
118
18,129
17,895
17,654
17,407
17,154
16,870
16,87017,15417,40717,65417,89518,12911833344317,162216,0880128,1560
       Capital Lease Obligations Min Short Term Debt
0
-15
0
661
513
360
206
51
18,129
17,895
17,654
17,407
17,154
16,870
16,87017,15417,40717,65417,89518,129512063605136610-150
       Deferred Long Term Asset Charges 
0
0
0
0
1,583
0
0
0
0
0
0
0
0
0
0000000001,5830000
       Warrants
0
0
0
0
215,304
0
0
0
0
0
0
0
0
0
000000000215,3040000
       Long-term Liabilities Other 
0
0
0
0
584
443
333
118
18,129
17,895
17,654
17,407
0
0
0017,40717,65417,89518,1291183334435840000
       Deferred Long Term Liability 
0
0
0
335
1,583
0
0
0
0
0
0
0
0
0
0000000001,583335000
> Total Stockholder Equity
0
-108,713
0
-122,751
67,711
152,315
141,086
129,091
115,054
195,583
180,258
166,437
151,718
225,848
225,848151,718166,437180,258195,583115,054129,091141,086152,31567,711-122,7510-108,7130
   Common Stock00000000000000
   Retained Earnings Total Equity00-246,665-228,366-210,900-194,341-178,440-164,972-152,137-140,5030000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
-5
-128
-147
-72
-45
-223
-134
539
539-134-223-45-72-147-128-5000000
   Capital Surplus 
0
0
0
0
9,488
304,452
306,063
307,659
309,542
406,555
408,669
413,325
0
0
00413,325408,669406,555309,542307,659306,063304,4529,4880000
   Treasury Stock00000000000000
   Other Stockholders Equity 
0
8,173
0
8,914
9,488
304,452
306,063
307,659
309,542
406,555
408,669
413,325
417,029
512,617
512,617417,029413,325408,669406,555309,542307,659306,063304,4529,4888,91408,1730



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-1,295
Gross Profit-1,295-1,295
 
Operating Income (+$)
Gross Profit-1,295
Operating Expense-83,696
Operating Income-84,991-84,991
 
Operating Expense (+$)
Research Development63,937
Selling General Administrative19,759
Selling And Marketing Expenses0
Operating Expense83,69683,696
 
Net Interest Income (+$)
Interest Income7,043
Interest Expense-0
Other Finance Cost-0
Net Interest Income7,043
 
Pretax Income (+$)
Operating Income-84,991
Net Interest Income7,043
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-76,271-93,711
EBIT - interestExpense = -84,991
-76,271
-76,408
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-84,991-76,271
Earnings Before Interest and Taxes (EBITDA)-83,696
 
After tax Income (+$)
Income Before Tax-76,271
Tax Provision-137
Net Income From Continuing Ops-70,836-76,408
Net Income-76,408
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses84,991
Total Other Income/Expenses Net8,720-7,043
 

Technical Analysis of Aura Biosciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Aura Biosciences Inc. The general trend of Aura Biosciences Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Aura Biosciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Aura Biosciences Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 7.1 < 8.133 < 8.5.

The bearish price targets are: 6.97 > 6.6 > 5.99.

Tweet this
Aura Biosciences Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Aura Biosciences Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Aura Biosciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Aura Biosciences Inc. The current macd is -0.23269046.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Aura Biosciences Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Aura Biosciences Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Aura Biosciences Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Aura Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartAura Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Aura Biosciences Inc. The current adx is 13.07.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Aura Biosciences Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Aura Biosciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Aura Biosciences Inc. The current sar is 7.87451937.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Aura Biosciences Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Aura Biosciences Inc. The current rsi is 41.42. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Aura Biosciences Inc Daily Relative Strength Index (RSI) ChartAura Biosciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Aura Biosciences Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Aura Biosciences Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Aura Biosciences Inc Daily Stochastic Oscillator ChartAura Biosciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Aura Biosciences Inc. The current cci is -102.00981311.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Aura Biosciences Inc Daily Commodity Channel Index (CCI) ChartAura Biosciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Aura Biosciences Inc. The current cmo is -19.0953094.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Aura Biosciences Inc Daily Chande Momentum Oscillator (CMO) ChartAura Biosciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Aura Biosciences Inc. The current willr is -79.7125951.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Aura Biosciences Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Aura Biosciences Inc Daily Williams %R ChartAura Biosciences Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Aura Biosciences Inc.

Aura Biosciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Aura Biosciences Inc. The current atr is 0.41212172.

Aura Biosciences Inc Daily Average True Range (ATR) ChartAura Biosciences Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Aura Biosciences Inc. The current obv is -333,315.

Aura Biosciences Inc Daily On-Balance Volume (OBV) ChartAura Biosciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Aura Biosciences Inc. The current mfi is 36.26.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Aura Biosciences Inc Daily Money Flow Index (MFI) ChartAura Biosciences Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Aura Biosciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-15MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-21MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-12BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Aura Biosciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Aura Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.420
Ma 20Greater thanMa 507.519
Ma 50Greater thanMa 1008.082
Ma 100Greater thanMa 2008.216
OpenGreater thanClose7.030
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Aura Biosciences Inc with someone you think should read this too:
  • Are you bullish or bearish on Aura Biosciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Aura Biosciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Aura Biosciences Inc

I send you an email if I find something interesting about Aura Biosciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Aura Biosciences Inc.

Receive notifications about Aura Biosciences Inc in your mailbox!